Snap stock dips before the open after CEO Evan Spiegel files to sell 1.26 million shares

Snap Inc shares were down about 0.3% in premarket trading on Wednesday, after a regulatory filing detailed a planned share sale tied to co-founder and CEO Evan Spiegel. Yahoo Finance

NEW YORK, December 31, 2025, 08:36 ET — Premarket.

  • Snap shares edged down in premarket trading after a Form 144 insider-sale notice tied to CEO Evan Spiegel.
  • The stock had closed up 2.4% on Tuesday in a weak broader market, with volume below its recent average.
  • Traders are watching year-end flows, follow-on insider filings and liquidity in thin holiday trading.

Snap Inc (SNAP.N) shares were down about 0.3% in premarket trading on Wednesday, after a regulatory filing detailed a planned share sale tied to co-founder and CEO Evan Spiegel.

The disclosure lands in the final session of 2025, when trading can be choppy and liquidity thin. In that kind of tape, insider-sale notices can have an outsized impact on sentiment even when they do not change a company’s fundamentals.

U.S. stocks ended slightly lower on Tuesday in holiday-thinned trade, and strategists said investors were shifting exposure as the calendar turns. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” Mark Hackett, chief market strategist at Nationwide, said. Reuters

A Form 144 filed on Tuesday showed Spiegel intends to sell 1,258,850 Snap shares, with an aggregate market value of about $10.0 million, through Wells Fargo Clearing Services, with an approximate sale date of Dec. 30. Form 144 is a notice filed with the U.S. Securities and Exchange Commission when an insider plans to sell shares under Rule 144.

The filing’s remarks referenced sales by The Captains Chest Revocable Trust, for which the document said Evan T. Spiegel is a trustee, and listed prior sales in early December. It also cited a Rule 10b5-1 plan date of Sept. 4, 2025; a 10b5-1 plan is a pre-arranged trading plan that can allow insiders to sell shares on a set schedule.

Snap closed Tuesday up 2.41% at $8.07, extending its winning streak to four sessions even as major indexes finished lower. Trading volume was 27.7 million shares, well below the stock’s 50-day average of 44.2 million, MarketWatch data showed.

The stock remained roughly 39% below its 52-week high of $13.28, hit in January, according to the same data.

Snap, Meta Platforms and Alphabet compete for digital advertising budgets, making the group sensitive to shifts in risk appetite and year-end portfolio positioning. Communication-services stocks outperformed the broader market on Tuesday, helped by gains in Meta.

For Snap, the immediate question is whether the market absorbs the insider supply quietly or demands a bigger discount in thin trading. A Form 144 does not guarantee a sale, but it signals intent and can shape near-term positioning.

Traders will also look for any follow-on disclosures that confirm completed transactions, and for signs of heavier volume once the regular session begins. Round-number levels like $8 can act as short-term markers because they tend to concentrate orders.

Beyond Wednesday’s session, investors are starting to focus on the next earnings window and what it implies for ad demand and user trends into 2026. Nasdaq’s earnings calendar currently estimates Snap’s next report for Feb. 3, 2026, though it notes the date is algorithm-derived and the company has not confirmed it.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments across global markets. He worked in investment research and market analysis before becoming a financial journalist and is a graduate of the Lahore University of Management Sciences (LUMS).

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade
Previous Story

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus
Next Story

Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus